Top compounds associated with response to TCF25


Feature Type Standardized
Nominal ANOVA
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.063 0.03
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.078 0.03
mRNA VX-680 CTRPv2 pan-cancer AAC 0.24 0.03
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.07 0.04
mRNA erastin CTRPv2 pan-cancer AAC -0.074 0.04
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.072 0.04
mRNA Axitinib FIMM pan-cancer AAC 0.33 0.04
mRNA Sunitinib FIMM pan-cancer AAC -0.36 0.04
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.04
Download CSV